Piper Jaffray analyst JP McKim raised his price target for Intuitive Surgical to $633 from $610 saying the company last night reported "solid" Q2 results with a beat on both the top and bottom line along with an increase in full year guidance. SP is gaining more traction, ION is set for a broader commercial launch, China is seeing growth, and the company is positioned for further expansion into bariatric, thoracic and deeper into general surgery, McKim tells investors in a research note. He believes hospital and surgeon demand for robotics remains very high and reiterates an Overweight rating on Intuitive Surgical shares.